Longeveron to Present Exciting Developments at Investment Conference
Longeveron to Present at the H.C. Wainwright 26th Annual Global Investment Conference
MIAMI — Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company specializing in cellular therapies for life-threatening and chronic aging-related conditions, has announced its participation in the H.C. Wainwright 26th Annual Global Investment Conference. This prestigious event is scheduled to occur from September 9 to September 11, 2024.
Presentation Details
The presentation by Longeveron will include key insights into their innovative projects and future directions. Here are the details:
Date: September 10, 2024
Time: 5:00 – 5:30 p.m. ET
Accessing the Webcast
Investors and interested parties can access the webcast of the conference presentation through the “Events and Presentations” section of Longeveron's website. A replay of the webcast will be available for 180 days following the event.
About Longeveron Inc.
Longeveron is at the forefront of biotechnology development, working towards pioneering regenerative medicines to meet unmet medical needs. Their lead investigational product, Lomecel-B™, is an allogeneic medicinal signaling cell therapy product, isolated from the bone marrow of young, healthy adult donors. This therapy possesses various potential mechanisms of action, which include pro-vascular, pro-regenerative, anti-inflammatory, and tissue repair effects. Lomecel-B™ is being developed for three significant indications: hypoplastic left heart syndrome (HLHS), Alzheimer’s disease (AD), and aging-related frailty.
Regulatory Designations
Significantly, the Lomecel-B™ development programs have garnered five essential designations from the U.S. FDA. The HLHS program has received Orphan Drug designation, Fast Track designation, and Rare Pediatric Disease designation, which highlight the potential impact of this therapy in pediatric populations. The Alzheimer's disease program holds the Regenerative Medicine Advanced Therapy (RMAT) designation and Fast Track designation, further underscoring its potential as a life-changing treatment for patients.
Commitment to Innovation
Longeveron's commitment to innovation is evident in its robust clinical development approach aimed at offering solutions for chronic conditions associated with aging. The company is concentrating on delivering regenerative therapies that not only treat symptoms but also aim to modify the disease processes involved.
Connecting with Longeveron
For more information, please visit Longeveron's official website. They are also active on several social media platforms, including LinkedIn and X, offering updates regarding their innovative treatments and company developments.
Investor Relations
For inquiries, investors can reach out to Derek Cole at Investor Relations Advisory Solutions via email.
Frequently Asked Questions
What is Longeveron Inc. known for?
Longeveron Inc. specializes in developing cellular therapies aimed at addressing chronic aging-related conditions and life-threatening diseases.
What is Lomecel-B™?
Lomecel-B™ is Longeveron’s lead investigational product, which is an allogeneic medicinal signaling cell therapy believed to provide regenerative benefits in various diseases.
When will Longeveron present at the conference?
Longeveron is scheduled to present on September 10, 2024, from 5:00 – 5:30 p.m. ET during the H.C. Wainwright 26th Annual Global Investment Conference.
How can I view the webcast of the presentation?
The webcast can be accessed in the “Events and Presentations” section of Longeveron’s website, with a replay available for 180 days after the event.
What regulatory designations has Lomecel-B™ received?
Lomecel-B™ has received several important designations, including Orphan Drug, Fast Track, and Rare Pediatric Disease designations for HLHS, and Regenerative Medicine Advanced Therapy and Fast Track designations for Alzheimer’s disease.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- Market Watch: Economic Focus Amid Mideast Turmoil
- Murphy Oil Corporation Unveils Early Tender Results for Debt
- Snap-on Incorporated Plans to Broadcast Third Quarter Results
- Gold Reserve's Update Signals Progress in Sale Proceedings
- Orbis Medicines Unveils R&D Expansion at Copenhagen Hub
- Exciting Gold Intersections Reported by Kobo Resources' Drilling
- Voter Perspectives on Crypto Policies: Trump vs. Harris
- Exciting New Store Launch of Red White & Blue Thrift Store
- Exploring Defensive Stocks with Exceptional Dividend Yields
- Unlocking New Exploration Potential: Nevada King Gold Corp.
Recent Articles
- Sana Biotechnology Welcomes Dhaval Patel as New CSO
- LifeMD to Showcase Innovations at Upcoming Investor Conferences
- IO Biotech to Present at Upcoming Healthcare Conferences
- Varonis Systems to Showcase Innovations at Investor Conference
- Flywire Corporation to Participate in Key Investor Conferences
- ORIC Pharmaceuticals Announces Participation in Investor Events
- Aura Biosciences Presents Phase 2 Data on Bel-sar Treatment
- Avista Announces Leadership Transition as CEO Dennis Vermillion Retires
- Structure Therapeutics Engages with Investors at Key Conferences
- Calavo Growers Inc. to Announce Q3 Financial Results
- DSS, Inc. Appoints Jason Grady as Interim CEO
- Shuttle Pharmaceuticals Faces Nasdaq Listing Non-Compliance
- Pineapple Energy Reports on Recent Financial Performance Insights
- DeNube Launches Revolutionary Decentralized GPU Cloud Network
- Massey Ferguson 9S Series Tractor: A Game Changer for Farmers
- Nvidia Earnings: An Underpriced Risk for Investors
- Oroco Resource Corp. PEA Update Webinar and Report Filing
- McEwen Mining Partners for 100% Renewable Energy in Copper Project
- Tech Stocks Struggle as Nvidia Earnings Approach
- Harvard Apparatus Secures $5 Million for Clinical Advancements
- Understanding Medical Properties Trust's Dividend Cut
- Understanding Roth IRAs and the Social Security Tax
- Understanding the Recent Decline of Icahn Enterprises
- Industrial Food Blanchers Market to Reach USD 574 Billion
- Brady Corporation to Host Earnings Conference Call
- Union Claims Against Chipotle Highlight Labor Rights Issues
- Nvidia Prepares for Second Quarter Earnings Report
- Ergodyne's Advanced Tool Tethering Solutions Announced
- Associa Canada Achieves Great Place To Work Certification
- Kingswood Capital Partners Closes $8 Million IPO for WORK MedTech
- Pixalate's Q2 2024 Fraudulent CTV Bundle IDs Report
- Aesthetic Medicine Market Growth to USD 205.32 Billion
- MasHash Unveils Revolutionary Cloud Mining Platform
- Mowi ASA (OSE: MOWI) Announces Senior Executive Share Options
- PDD Holdings Faces Challenges Amidst Growth Fluctuations
- V3V Ventures Bolsters Blockchain Innovation with U2U and CrossCurve
- WORK Medical Technology Group LTD Completes IPO Successfully
- Jack Dorsey's Vision for Block as a Crypto Leader
- Key Insights on Upcoming Stock Splits This Week
- Shell plc Announces Share Buy-Back Transactions
- Dermal Fillers Market Growth and Trends
- Growth Prospects of the Wire Cutting Machine Market
- BioNexus Gene Lab Invests RM 1 Million in AI Healthcare Tech
- Genmab to Share Insights at Global Healthcare Conference
- Mixed Market Performance as Investors Eye Nvidia Earnings
- Associa Achieves Prestigious Great Place to Work Standard
- Automotive Auxiliary Lamps Market Growth Forecasts
- Intragastric Balloons Market Growth Insights and Trends
- Immunoassay Market Set to Thrive with 5.8% CAGR Growth
- NBME Launches Fee Assistance Program for Medical Students